Report Detail

Request for Sample of this report

Other Global Oncolytic Virus CDMO Services Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4571725
    • |
  • 18 December, 2023
    • |
  • Global
    • |
  • 127 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Oncolytic Virus CDMO Services market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
Oncolytic virus CDMO service is a customized service provided to customers for the development and production of oncolytic virus vectors.
Oncolytic viruses (OVs) therapy is a new approach to treating tumors, which works by directly killing tumor cells and inducing the body's immune response. However, natural oncolytic viruses have certain limitations. Therefore, various viruses need to be used as vectors to enhance or weaken viral virulence through genetic modification and introduce new functional genes to improve their oncolytic effect. Currently, herpes simplex virus, adenovirus, vaccinia virus, vesicular stomatitis virus, measles virus, mumps virus, polio virus, etc. can be used as oncolytic virus vectors. These viral vectors can target and kill different tumor cells through different genetic modification methods, achieving better oncolytic effects.
Oncolytic virus CDMO services can accelerate the R&D and production process of oncolytic viruses, provide customers with high-quality oncolytic virus products, and promote innovation in the field of tumor treatment.
The Global Info Research report includes an overview of the development of the Oncolytic Virus CDMO Services industry chain, the market status of R&D (Oncolytic Herpes Simplex Virus, Oncolytic Adenovirus), Biopharmaceutical Manufacturers (Oncolytic Herpes Simplex Virus, Oncolytic Adenovirus), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oncolytic Virus CDMO Services.
Regionally, the report analyzes the Oncolytic Virus CDMO Services markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oncolytic Virus CDMO Services market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oncolytic Virus CDMO Services market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oncolytic Virus CDMO Services industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oncolytic Herpes Simplex Virus, Oncolytic Adenovirus).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oncolytic Virus CDMO Services market.
Regional Analysis: The report involves examining the Oncolytic Virus CDMO Services market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oncolytic Virus CDMO Services market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oncolytic Virus CDMO Services:
Company Analysis: Report covers individual Oncolytic Virus CDMO Services players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oncolytic Virus CDMO Services This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (R&D, Biopharmaceutical Manufacturers).
Technology Analysis: Report covers specific technologies relevant to Oncolytic Virus CDMO Services. It assesses the current state, advancements, and potential future developments in Oncolytic Virus CDMO Services areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oncolytic Virus CDMO Services market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Oncolytic Virus CDMO Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Oncolytic Herpes Simplex Virus
Oncolytic Adenovirus
Oncolytic Vaccinia Virus
Others
Market segment by Application
R&D
Biopharmaceutical Manufacturers
Others
Market segment by players, this report covers
Recipharm (Vibalogics)
IDT Biologika
FUJIFILM Diosynth Biotechnologies
Exothera
Lonza
Creative Biolabs
Takara Bio
Libentech
ABL
Nabios
Halix
Obio Technology
Porton Advanced
WuXi ATU
Genevoyager
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncolytic Virus CDMO Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncolytic Virus CDMO Services, with revenue, gross margin and global market share of Oncolytic Virus CDMO Services from 2018 to 2023.
Chapter 3, the Oncolytic Virus CDMO Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Oncolytic Virus CDMO Services market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncolytic Virus CDMO Services.
Chapter 13, to describe Oncolytic Virus CDMO Services research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Oncolytic Virus CDMO Services
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Oncolytic Virus CDMO Services by Type
    • 1.3.1 Overview: Global Oncolytic Virus CDMO Services Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Oncolytic Virus CDMO Services Consumption Value Market Share by Type in 2022
    • 1.3.3 Oncolytic Herpes Simplex Virus
    • 1.3.4 Oncolytic Adenovirus
    • 1.3.5 Oncolytic Vaccinia Virus
    • 1.3.6 Others
  • 1.4 Global Oncolytic Virus CDMO Services Market by Application
    • 1.4.1 Overview: Global Oncolytic Virus CDMO Services Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 R&D
    • 1.4.3 Biopharmaceutical Manufacturers
    • 1.4.4 Others
  • 1.5 Global Oncolytic Virus CDMO Services Market Size & Forecast
  • 1.6 Global Oncolytic Virus CDMO Services Market Size and Forecast by Region
    • 1.6.1 Global Oncolytic Virus CDMO Services Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Oncolytic Virus CDMO Services Market Size by Region, (2018-2029)
    • 1.6.3 North America Oncolytic Virus CDMO Services Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Oncolytic Virus CDMO Services Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Oncolytic Virus CDMO Services Market Size and Prospect (2018-2029)
    • 1.6.6 South America Oncolytic Virus CDMO Services Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Oncolytic Virus CDMO Services Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Recipharm (Vibalogics)
    • 2.1.1 Recipharm (Vibalogics) Details
    • 2.1.2 Recipharm (Vibalogics) Major Business
    • 2.1.3 Recipharm (Vibalogics) Oncolytic Virus CDMO Services Product and Solutions
    • 2.1.4 Recipharm (Vibalogics) Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Recipharm (Vibalogics) Recent Developments and Future Plans
  • 2.2 IDT Biologika
    • 2.2.1 IDT Biologika Details
    • 2.2.2 IDT Biologika Major Business
    • 2.2.3 IDT Biologika Oncolytic Virus CDMO Services Product and Solutions
    • 2.2.4 IDT Biologika Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 IDT Biologika Recent Developments and Future Plans
  • 2.3 FUJIFILM Diosynth Biotechnologies
    • 2.3.1 FUJIFILM Diosynth Biotechnologies Details
    • 2.3.2 FUJIFILM Diosynth Biotechnologies Major Business
    • 2.3.3 FUJIFILM Diosynth Biotechnologies Oncolytic Virus CDMO Services Product and Solutions
    • 2.3.4 FUJIFILM Diosynth Biotechnologies Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
  • 2.4 Exothera
    • 2.4.1 Exothera Details
    • 2.4.2 Exothera Major Business
    • 2.4.3 Exothera Oncolytic Virus CDMO Services Product and Solutions
    • 2.4.4 Exothera Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Exothera Recent Developments and Future Plans
  • 2.5 Lonza
    • 2.5.1 Lonza Details
    • 2.5.2 Lonza Major Business
    • 2.5.3 Lonza Oncolytic Virus CDMO Services Product and Solutions
    • 2.5.4 Lonza Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Lonza Recent Developments and Future Plans
  • 2.6 Creative Biolabs
    • 2.6.1 Creative Biolabs Details
    • 2.6.2 Creative Biolabs Major Business
    • 2.6.3 Creative Biolabs Oncolytic Virus CDMO Services Product and Solutions
    • 2.6.4 Creative Biolabs Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Creative Biolabs Recent Developments and Future Plans
  • 2.7 Takara Bio
    • 2.7.1 Takara Bio Details
    • 2.7.2 Takara Bio Major Business
    • 2.7.3 Takara Bio Oncolytic Virus CDMO Services Product and Solutions
    • 2.7.4 Takara Bio Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Takara Bio Recent Developments and Future Plans
  • 2.8 Libentech
    • 2.8.1 Libentech Details
    • 2.8.2 Libentech Major Business
    • 2.8.3 Libentech Oncolytic Virus CDMO Services Product and Solutions
    • 2.8.4 Libentech Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Libentech Recent Developments and Future Plans
  • 2.9 ABL
    • 2.9.1 ABL Details
    • 2.9.2 ABL Major Business
    • 2.9.3 ABL Oncolytic Virus CDMO Services Product and Solutions
    • 2.9.4 ABL Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 ABL Recent Developments and Future Plans
  • 2.10 Nabios
    • 2.10.1 Nabios Details
    • 2.10.2 Nabios Major Business
    • 2.10.3 Nabios Oncolytic Virus CDMO Services Product and Solutions
    • 2.10.4 Nabios Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Nabios Recent Developments and Future Plans
  • 2.11 Halix
    • 2.11.1 Halix Details
    • 2.11.2 Halix Major Business
    • 2.11.3 Halix Oncolytic Virus CDMO Services Product and Solutions
    • 2.11.4 Halix Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Halix Recent Developments and Future Plans
  • 2.12 Obio Technology
    • 2.12.1 Obio Technology Details
    • 2.12.2 Obio Technology Major Business
    • 2.12.3 Obio Technology Oncolytic Virus CDMO Services Product and Solutions
    • 2.12.4 Obio Technology Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Obio Technology Recent Developments and Future Plans
  • 2.13 Porton Advanced
    • 2.13.1 Porton Advanced Details
    • 2.13.2 Porton Advanced Major Business
    • 2.13.3 Porton Advanced Oncolytic Virus CDMO Services Product and Solutions
    • 2.13.4 Porton Advanced Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Porton Advanced Recent Developments and Future Plans
  • 2.14 WuXi ATU
    • 2.14.1 WuXi ATU Details
    • 2.14.2 WuXi ATU Major Business
    • 2.14.3 WuXi ATU Oncolytic Virus CDMO Services Product and Solutions
    • 2.14.4 WuXi ATU Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 WuXi ATU Recent Developments and Future Plans
  • 2.15 Genevoyager
    • 2.15.1 Genevoyager Details
    • 2.15.2 Genevoyager Major Business
    • 2.15.3 Genevoyager Oncolytic Virus CDMO Services Product and Solutions
    • 2.15.4 Genevoyager Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Genevoyager Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Oncolytic Virus CDMO Services Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Oncolytic Virus CDMO Services by Company Revenue
    • 3.2.2 Top 3 Oncolytic Virus CDMO Services Players Market Share in 2022
    • 3.2.3 Top 6 Oncolytic Virus CDMO Services Players Market Share in 2022
  • 3.3 Oncolytic Virus CDMO Services Market: Overall Company Footprint Analysis
    • 3.3.1 Oncolytic Virus CDMO Services Market: Region Footprint
    • 3.3.2 Oncolytic Virus CDMO Services Market: Company Product Type Footprint
    • 3.3.3 Oncolytic Virus CDMO Services Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Oncolytic Virus CDMO Services Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Oncolytic Virus CDMO Services Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Oncolytic Virus CDMO Services Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Oncolytic Virus CDMO Services Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Oncolytic Virus CDMO Services Consumption Value by Type (2018-2029)
  • 6.2 North America Oncolytic Virus CDMO Services Consumption Value by Application (2018-2029)
  • 6.3 North America Oncolytic Virus CDMO Services Market Size by Country
    • 6.3.1 North America Oncolytic Virus CDMO Services Consumption Value by Country (2018-2029)
    • 6.3.2 United States Oncolytic Virus CDMO Services Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Oncolytic Virus CDMO Services Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Oncolytic Virus CDMO Services Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Oncolytic Virus CDMO Services Consumption Value by Type (2018-2029)
  • 7.2 Europe Oncolytic Virus CDMO Services Consumption Value by Application (2018-2029)
  • 7.3 Europe Oncolytic Virus CDMO Services Market Size by Country
    • 7.3.1 Europe Oncolytic Virus CDMO Services Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Oncolytic Virus CDMO Services Market Size and Forecast (2018-2029)
    • 7.3.3 France Oncolytic Virus CDMO Services Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Oncolytic Virus CDMO Services Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Oncolytic Virus CDMO Services Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Oncolytic Virus CDMO Services Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Oncolytic Virus CDMO Services Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Oncolytic Virus CDMO Services Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Oncolytic Virus CDMO Services Market Size by Region
    • 8.3.1 Asia-Pacific Oncolytic Virus CDMO Services Consumption Value by Region (2018-2029)
    • 8.3.2 China Oncolytic Virus CDMO Services Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Oncolytic Virus CDMO Services Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Oncolytic Virus CDMO Services Market Size and Forecast (2018-2029)
    • 8.3.5 India Oncolytic Virus CDMO Services Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Oncolytic Virus CDMO Services Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Oncolytic Virus CDMO Services Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Oncolytic Virus CDMO Services Consumption Value by Type (2018-2029)
  • 9.2 South America Oncolytic Virus CDMO Services Consumption Value by Application (2018-2029)
  • 9.3 South America Oncolytic Virus CDMO Services Market Size by Country
    • 9.3.1 South America Oncolytic Virus CDMO Services Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Oncolytic Virus CDMO Services Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Oncolytic Virus CDMO Services Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Oncolytic Virus CDMO Services Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Oncolytic Virus CDMO Services Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Oncolytic Virus CDMO Services Market Size by Country
    • 10.3.1 Middle East & Africa Oncolytic Virus CDMO Services Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Oncolytic Virus CDMO Services Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Oncolytic Virus CDMO Services Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Oncolytic Virus CDMO Services Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Oncolytic Virus CDMO Services Market Drivers
  • 11.2 Oncolytic Virus CDMO Services Market Restraints
  • 11.3 Oncolytic Virus CDMO Services Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Oncolytic Virus CDMO Services Industry Chain
  • 12.2 Oncolytic Virus CDMO Services Upstream Analysis
  • 12.3 Oncolytic Virus CDMO Services Midstream Analysis
  • 12.4 Oncolytic Virus CDMO Services Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Oncolytic Virus CDMO Services. Industry analysis & Market Report on Oncolytic Virus CDMO Services is a syndicated market report, published as Global Oncolytic Virus CDMO Services Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Oncolytic Virus CDMO Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,208.56
    		4,812.84
    		6,417.12
    		531,604.80
    		797,407.20
    		1,063,209.60
    		292,702.80
    		439,054.20
    		585,405.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo